Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body radiotherapy
Nikhil Sebastian, Trudy C. Wu, Jose G. Bazan, et al.
Radiotherapy and Oncology (2019) Vol. 134, pp. 151-157
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

External validation of radiobiological models for local control prediction in lung cancer patients treated with stereotactic body radiation therapy
Bao-Tian Huang, Pei-Xian Lin, Ying Wang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
The Combination of Radiotherapy With Immunotherapy and Potential Predictive Biomarkers for Treatment of Non-Small Cell Lung Cancer Patients
Meng Lu, Jianfang Xu, Ying Ye, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
Baiqiang Dong, Xuan Zhu, Runzhe Chen, et al.
Diagnostics (2023) Vol. 13, Iss. 2, pp. 313-313
Open Access | Times Cited: 8
Association of Pre- and Posttreatment Neutrophil–Lymphocyte Ratio With Recurrence and Mortality in Locally Advanced Non-Small Cell Lung Cancer
Nikhil Sebastian, Rohit Raj, Rahul N. Prasad, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 23
Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer
Xinyue Wang, Lianjing Cao, Shouying Li, et al.
Journal of Cancer (2019) Vol. 10, Iss. 26, pp. 6703-6710
Open Access | Times Cited: 21
Neutrophil–Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer
Anshu Punjabi, Emma Barrett, Andrew Cheng, et al.
Clinical Oncology (2021) Vol. 33, Iss. 8, pp. e331-e338
Open Access | Times Cited: 17
Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
Karen Huang, Sharan Prasad, Sung Jun, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Tumor immune microenvironment in cancer patients with leukocytosis
Kyung Hwan Kim, Nam Suk Sim, Jee Suk Chang, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 7, pp. 1265-1277
Closed Access | Times Cited: 16
Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD-1 antibodies
Tomohiro Tanaka, Tatsuya Yoshida, Ken Masuda, et al.
Respiratory Investigation (2022) Vol. 61, Iss. 1, pp. 74-81
Open Access | Times Cited: 10
Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy
Fang Fang, Zhen Jia, Hongliang Xie, et al.
The Clinical Respiratory Journal (2024) Vol. 18, Iss. 5
Open Access | Times Cited: 1
Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non‐small‐cell lung cancer treated with chemoradiotherapy
Ela Delikgöz Soykut, Yasemi̇n Kemal, Cengiz Karaçin, et al.
Journal of Medical Imaging and Radiation Oncology (2021) Vol. 66, Iss. 1, pp. 146-157
Closed Access | Times Cited: 9
Pretreatment Neutrophil-to-Lymphocyte Ratio and Smoking History as Prognostic Factors in Advanced Non–Small Cell Lung Cancer Patients Treated with Osimertinib
Ji Young Park, Seung Hun Jang, Chang Youl Lee, et al.
Tuberculosis & respiratory diseases (2022) Vol. 85, Iss. 2, pp. 155-164
Open Access | Times Cited: 5
Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal clinical cutoff point
Nikhil V. Kotha, Daniel R. Cherry, Alex K. Bryant, et al.
Clinical and Translational Radiation Oncology (2021) Vol. 28, pp. 133-140
Open Access | Times Cited: 6
Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
Wenrui Chen, Li Wang, Yu Hou, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 4
Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer
Wencai Li, Zhen Wang, Jie Gao, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 1887-1896
Open Access | Times Cited: 5
Stereotactic body radiation therapy (SBRT) of adrenal gland metastases in oligometastatic and oligoprogressive disease
Leonid B. Reshko, Jeremy Gaskins, Craig L. Silverman, et al.
Reports of Practical Oncology & Radiotherapy (2021)
Open Access | Times Cited: 5
The Prognostic Role of Pretreatment Neutrophil to Lymphocyte Ratio (NLR) in Malignant Adrenal Lesions Treated With Stereotactic Body Radiation Therapy (SBRT)
Matthew N. Mills, Abhinav V. Reddy, L Richardson, et al.
American Journal of Clinical Oncology (2019) Vol. 42, Iss. 12, pp. 945-950
Closed Access | Times Cited: 4
Neutrophil‑to‑lymphocyte ratio as a prognostic predictor for patients with cancer treated with stereotactic body radiation therapy: A meta‑analysis
YU Yi-pin, Duoting Tan, Can Liao, et al.
Molecular and Clinical Oncology (2022) Vol. 16, Iss. 5
Open Access | Times Cited: 3
Predicting if lung cancer will relapse—The role of neutrophil/lymphocyte ratio
Abigail Chan, Søren M. Bentzen, Amit Rout, et al.
Hematology/Oncology and Stem Cell Therapy (2021) Vol. 16, Iss. 2, pp. 158-161
Open Access | Times Cited: 4
Developing a clinical-radiomic prediction model for 3-year cancer-specific survival in lung cancer patients treated with stereotactic body radiation therapy
Bao-Tian Huang, Ying Wang, Pei-Xian Lin
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access
Incorporating the inflammation-related parameters enhances the performance of the nomogram for predicting local control in lung cancer patients treated with stereotactic body radiation therapy
Bao-Tian Huang, Pei-Xian Lin, Limei Luo, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access
Systemic Immune–Inflammatory Index and Other Inflammatory Marker Variations in Oral Squamous Cell Carcinoma Management
Adrian Ionuț Nicoară, Ciprian Ioan Roi, Alexandra Roi, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1840-1840
Open Access
Bystander Effects and Unintended Consequences: Time to Include the Spleen in Radiation Therapy Planning
Matthew S. Katz
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 3
Prognostic markers including immune and inflammatory factors predict outcomes in patients receiving postoperative radiation therapy for cholangiocarcinoma
Yuki Mukai, Ryusei Matsuyama, Madoka Sugiura, et al.
Asia-Pacific Journal of Clinical Oncology (2022) Vol. 19, Iss. 1, pp. 226-233
Closed Access | Times Cited: 1
Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) in Metastatic Sarcoma
Eashwar Somasundaram, Timothy D. Smile, Ahmed Halima, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top